Head-to-Head

Ironwood Pharmaceuticals, Inc. - Class A vs. Eli Lilly & Co.

IRWD

Ironwood Pharmaceuticals, Inc. - Class A

$4.25 +2.91%

VS LLY

Eli Lilly & Co.

$1156.73 -1.52%

Eli Lilly & Co. (LLY) comes out ahead, leading on 6 of 9 compared factors.

Size & Scale

IRWDLLY
Market Cap $682.44 million $1.05 trillion
Revenue (TTM) $389.32 million $79.67 billion
Net Income (TTM) $129.87 million $26.71 billion

LLY leads on 3 of 3 size & scale factors.

Valuation

IRWDLLY
P/E Ratio 5.52 38.83
Price / Book -4.22 30.90
Price / Sales 1.75 13.14

IRWD leads on 3 of 3 valuation factors.

Profitability

IRWDLLY
Net Margin 33.36% 33.53%
Return on Equity -80.24% 78.84%

LLY leads on 2 of 2 profitability factors.

Dividend

IRWDLLY
Dividend Yield — 0.60%
Payout Ratio — 23.23

IRWD and LLY split the dividend factors evenly.

Risk & Sentiment

IRWDLLY
Short Interest 11.02% 1.29%

LLY leads on 1 of 1 risk & sentiment factors.

Dig deeper: IRWD overview, IRWD financials, LLY overview, LLY financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.